Literature DB >> 7242704

A pharmacological method to estimate the pKi of competitive inhibitors of agonist uptake processes in isolated tissues.

T P Kenakin.   

Abstract

An equation is derived from a mathematical model (proposed by Furchgott) which, under certain circumstances, estimates the pKI (-log dissociation constant) of a competitive inhibitor of agonist uptake by utilizing the sensitization of isolated tissues, to the substrate-agonist, by uptake inhibition. The method is theoretically more sound and appears to be improved by the use of potency-ratios of the substrate-agonist and an agonist which is not a substrate for the uptake process since this allows for the detection and correction of receptor and toxic effects of uptake inhibitors. The pKI values of cocaine, desmethylimipramine and imipramine for the neuronal uptake of norepinephrine were estimated by this method in guinea-pig tracheae and left atria. Also, the pKI values for 17 beta-oestradiol, corticosterone, clonidine and metanephrine for the extraneuronal uptake of isoproterenol were estimated in guinea-pig tracheae (and cat left atria for 17 beta-oestradiol). All estimates were consistent with literature pKI values obtained biochemically with radiolabelled substrates.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7242704     DOI: 10.1007/bf00505300

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  INHIBITION OF NORADRENALINE UPTAKE BY DRUGS.

Authors:  L L IVERSEN
Journal:  J Pharm Pharmacol       Date:  1965-01       Impact factor: 3.765

2.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

3.  The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart.

Authors:  A S Burgen; L L Iversen
Journal:  Br J Pharmacol Chemother       Date:  1965-08

4.  The stability of noradrenaline in physiological saline solutions.

Authors:  I E Hughes; J A Smith
Journal:  J Pharm Pharmacol       Date:  1978-02       Impact factor: 3.765

5.  Inhibition of noradrenaline uptake 2 in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines.

Authors:  P J Salt
Journal:  Eur J Pharmacol       Date:  1972-12       Impact factor: 4.432

6.  On the mechanism of supersensitivity to norepinephrine in the denervated cat spleen.

Authors:  S Brimijoin; S Pluchino; U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

7.  Convenient apparatus for recording contractions of isolated heart muscle.

Authors:  J R Blinks
Journal:  J Appl Physiol       Date:  1965-07       Impact factor: 3.531

8.  The potentiation of the responses to noradrenaline and isoprenaline of the guinea-pig isolated tracheal chain preparation by desipramine, cocaine, phentolamine, phenoxybenzamine, guanethidine, metanephrine and cooling.

Authors:  R W Foster
Journal:  Br J Pharmacol Chemother       Date:  1967-11

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  The role of uptake of noradrenaline of its positive inotropic effect in relation to muscle geometry. Statistical evaluation.

Authors:  F Ebner; D R Waud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

View more
  3 in total

1.  Procedure for calculation of potency and efficacy for ligands acting on Gs- and Gi-coupled receptors.

Authors:  Eddi Meier; Arne Schousboe; Bo Belhage
Journal:  Neurochem Res       Date:  2012-09-26       Impact factor: 3.996

2.  Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.

Authors:  L N Axelsen; W Keung; H D Pedersen; E Meier; D Riber; A L Kjølbye; J S Petersen; S D Proctor; N-H Holstein-Rathlou; G D Lopaschuk
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.

Authors:  Giovanny Aguilera-Durán; Antonio Romo-Mancillas
Journal:  Molecules       Date:  2020-09-25       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.